Arca Biopharma | ABIO - Interest Expense On Debt


Arca Biopharma reported $0 in Interest Expense on Debt for its fiscal quarter ending in March of 2025.





Interest Expense On Debt Change Date
Amgen USD 653M 32M Dec/2025
Arca Biopharma USD 0 0 Mar/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Capricor Therapeutics 581K 581K Dec/2024
Cipla INR 140.3M 8.5M Dec/2025
Compugen USD 954K 116K Sep/2025
CSL USD 104M 136M Jun/2025
Cytokinetics USD 26.32M 2.06M Sep/2025
Daiichi Sankyo JPY 2.16B 1.33B Dec/2025
Gilead Sciences USD 255M 1000K Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
Grifols EUR 156.07M 31.46M Sep/2025
Laboratory Of America USD 56M 1.1M Sep/2025
Myriad Genetics USD 800K 100K Mar/2025
Otsuka Holdings JPY 1.34B 8.39B Sep/2025
Pfizer USD 711M 59M Dec/2025
United Therapeutics USD 3M 4.3M Sep/2025